Skip to main content
. 2021 Jul 22;13(7):e16554. doi: 10.7759/cureus.16554

Table 1. Patient characteristics and comorbidities.

ALD: Alcohol liver disease; CLD: Chronic liver disease; COPD: Chronic obstructive pulmonary disease; CXR: Chest X-ray; DMx1: Diabetes mellitus type 1; DMx2: Diabetes mellitus type 2; Frailty: Dalhousie Frailty (Rockwood) score of 4 or more classified as frail; IHD: Ischemic heart disease; ILD: Interstitial lung disease; IQR: Interquartile range; N: Number of cases; PE: Pulmonary embolism.

Variable Swab negative, N = 630 Swab positive, N = 112 Total P-value
Age, years 68.4 (19.7) 70.9 (17.6) 68.8 (19.4) 0.21
Sex, % male (N) 47.9% (302) 56.3% (63) 49.2% (365) 0.11
Ever smoker, % (N) 3.9% (24) 16.5% (18) 5.8% (42) <0.001
CXR infiltrates, % (N) 34.1% (215) 56.3% (63) 37.5% (278) <0.001
Comorbidities        
Diabetes, % (N) Type 1/Type 2 0.5% (3) 2.6% (16) 0.9% (1) 5.5% (6) 0.6% (4) 3.1% (22) 0.48 0.13
Diarrhea, % (N) 9.1% (57) 29.5% (33) 12.1% (90) <0.001
IHD, % (N) 17.2% (105) 29.4% (32) 19.1% (137) 0.003
Asthma/COPD/ILD % (N) 10.3% (63) 21.1% (23) 12.0% (86) 0.001
Hypertension, % (N) 10.3% (63) 19.3% (21) 11.7% (84) 0.007
Dementia, % (N) 8.4% (51) 20.2% (22) 10.2% (73) <0.001
Frailty, % (N) 12.0% (73) 22.9% (25) 13.6% (98) 0.002
ALD-CLD, % (N) 1.5% (9) 1.8% (2) 1.5% (11) 0.68
Malignancy, % (N) 2.6% (16) 14.7% (16) 4.5% (32) <0.001
PE, % (N) 1.0% (6) 3.7% (4) 1.4% (10) 0.051
Lymphocyte count, 109/ L* 1.12 [0.71-1.68] 1.04 [0.63-1.5] 1.12 [0.71-1.66] 0.27
Lymphocyte count < 1.5x109/ L 69.8% (440) 75.0% (84) 70.6% (524) 0.27